Showing results (321-330 of 384) with videos related to
Sort By:
Pageof 39
International Journal of Cancer|June 1, 2006
Assessment of gene promoter hypermethylation for detection of cervical neoplasiaG Bea A Wisman, Esther R Nijhuis, Mohammad O Hoque, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributionsSteven J Skates, Nora Horick, Yinhua Yu, et al.Plos One|July 23, 2014
Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-offAniek Boers, Lorian Slagter-Menkema, Bettien M van Hemel, et al.Frontiers in Human Neuroscience|November 18, 2021
Early Screening of Visual Processing Dysfunctions in Children Born Very or Extremely PretermMarlou J G Kooiker, Maud M van Gils, Ymie J van der Zee, et al.Epigenetics|August 7, 2018
Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancerWina Verlaat, Robert W Van Leeuwen, Putri W Novianti, et al.Current Pharmaceutical Design|May 18, 2012
Multiple VEGF family members are simultaneously expressed in ovarian cancer: a proposed model for bevacizumab resistanceArne R M van der Bilt, Ate G J van der Zee, Elisabeth G E de Vries, et al.Gynecologic Oncology|March 26, 2005
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinomaF Y F L De Vos, A M E Bos, M Schaapveld, et al.International Journal of Radiation Oncology, Biology, Physics|August 15, 2006
Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgeryEsther R Nijhuis, Ate G J van der Zee, Bertha A in 't Hout, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 25, 2010
Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumorsIngrid T G W Bijsmans, Kim M Smits, Pauline de Graeff, et al.British Journal of Cancer|August 2, 2006
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studiesP de Graeff, J Hall, A P G Crijns, et al.Pageof 39